Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Kester

Showing results (11-20 of 149) with videos related to

Pageof 15
Sort By:
Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology|October 4, 2011
Calcium phosphate-based composite nanoparticles in bioimaging and therapeutic delivery applicationsAmra Tabaković, Mark Kester, James H Adair
Anti-Cancer Agents in Medicinal Chemistry|June 29, 2011
Ceramide-based therapeutics for the treatment of cancerBrian M Barth, Myles C Cabot, Mark Kester
The Journal of Knee Surgery|May 31, 2011
The influence of material and design on total knee replacement wearAaron Essner, Lizeth Herrera, Phillip Hughes, et al.
Journal of Lipid Research|November 16, 2012
Sphingolipids: regulators of crosstalk between apoptosis and autophagyMegan M Young, Mark Kester, Hong-Gang Wang
American Journal of Physiology. Cell Physiology|February 27, 2009
State-dependent block of HERG potassium channels by R-roscovitine: implications for cancer therapySindura B Ganapathi, Mark Kester, Keith S Elmslie
The Journal of Knee Surgery|April 26, 2014
Emerging technologies in arthroplasty: additive manufacturingSamik Banerjee, Gene Kulesha, Mark Kester, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 4, 2005
Systemic delivery of liposomal short-chain ceramide limits solid tumor growth in murine models of breast adenocarcinomaThomas C Stover, Arati Sharma, Gavin P Robertson, et al.
American Journal of Physiology. Heart and Circulatory Physiology|August 30, 2008
Ether-linked diglycerides inhibit vascular smooth muscle cell growth via decreased MAPK and PI3K/Akt signalingKristy L Houck, Todd E Fox, Lakshman Sandirasegarane, et al.
Journal of Leukocyte Biology|March 29, 2008
Inhibition of corneal inflammation by liposomal delivery of short-chain, C-6 ceramideYan Sun, Todd Fox, Gautam Adhikary, et al.
Cancer Biology & Therapy|July 8, 2017
Therapeutic implications of bioactive sphingolipids: A focus on colorectal cancerE Ramsay Camp, Logan D Patterson, Mark Kester, et al.
Pageof 15

Showing results (11-20 of 149) with videos related to

Sort By:
Pageof 15
Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology|October 4, 2011
Calcium phosphate-based composite nanoparticles in bioimaging and therapeutic delivery applicationsAmra Tabaković, Mark Kester, James H Adair
Anti-Cancer Agents in Medicinal Chemistry|June 29, 2011
Ceramide-based therapeutics for the treatment of cancerBrian M Barth, Myles C Cabot, Mark Kester
The Journal of Knee Surgery|May 31, 2011
The influence of material and design on total knee replacement wearAaron Essner, Lizeth Herrera, Phillip Hughes, et al.
Journal of Lipid Research|November 16, 2012
Sphingolipids: regulators of crosstalk between apoptosis and autophagyMegan M Young, Mark Kester, Hong-Gang Wang
American Journal of Physiology. Cell Physiology|February 27, 2009
State-dependent block of HERG potassium channels by R-roscovitine: implications for cancer therapySindura B Ganapathi, Mark Kester, Keith S Elmslie
The Journal of Knee Surgery|April 26, 2014
Emerging technologies in arthroplasty: additive manufacturingSamik Banerjee, Gene Kulesha, Mark Kester, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 4, 2005
Systemic delivery of liposomal short-chain ceramide limits solid tumor growth in murine models of breast adenocarcinomaThomas C Stover, Arati Sharma, Gavin P Robertson, et al.
American Journal of Physiology. Heart and Circulatory Physiology|August 30, 2008
Ether-linked diglycerides inhibit vascular smooth muscle cell growth via decreased MAPK and PI3K/Akt signalingKristy L Houck, Todd E Fox, Lakshman Sandirasegarane, et al.
Journal of Leukocyte Biology|March 29, 2008
Inhibition of corneal inflammation by liposomal delivery of short-chain, C-6 ceramideYan Sun, Todd Fox, Gautam Adhikary, et al.
Cancer Biology & Therapy|July 8, 2017
Therapeutic implications of bioactive sphingolipids: A focus on colorectal cancerE Ramsay Camp, Logan D Patterson, Mark Kester, et al.
Pageof 15